Literature DB >> 728913

Immunomodulating effects of BM 12.531 in animals and tolerance in man.

U Bicker.   

Abstract

BM 12.531, a 2-cyansubstituted aziridine, has interesting therapeutic and immunomodulating effects. Antitumor effects in Meth A sarcoma in mice and an increase in resistance to Candida albicans infection in mice have been found. It was demonstrated that BM 12.531 can modulate the immune system in animals (DTH lymphocyte transformation, etc). It was also shown that BM 12.531 can restore the immune response in animals, where this has been suppressed by cyclophosphamide. In a phase I study in cancer patients it was demonstrated that BM 12.531 is very well-tolerated. A dose-dependent increase was found in the percentage of spontaneous T lymphocytes in cancer patients after the administration of BM 12.531.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 728913

Source DB:  PubMed          Journal:  Cancer Treat Rep        ISSN: 0361-5960


  3 in total

1.  Reduction of acute toxicity of cyclophosphamide and X-rays by the new immunomodulating compound BM 12.531.

Authors:  U Bicker; K D Friedberg; G Hebold; K Mengel
Journal:  Experientia       Date:  1979-10-15

2.  The action of azimexone on the cells of the hemopoietic system in mice, especially after damage with X-rays.

Authors:  K D Friedberg; K Mengel; E Schlick
Journal:  Radiat Environ Biophys       Date:  1983       Impact factor: 1.925

3.  Effect of azimexon (BM 12.531) on mouse granulocyte-macrophage and monocyte-macrophage progenitor cells.

Authors:  J C Jeng; K F McCarthy; M A Chirigos; J F Weiss
Journal:  Experientia       Date:  1982-01-15
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.